Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Picker appoints new CEO

Chris Graham to focus on person-centred care

- PMLiVE

Wave strengthens programme delivery team

Dr Andrea Hamlin and Aashni Shah joins firm

- PMLiVE

Salix & Co represents IHM

Will handle the firm’s media relations

Reading the signals

The future is foreseeable, if you know where to look

- PMLiVE

US scientists still wary of Gottlieb’s industry ties

Pharma professionals undertake survey conducted by SAB

- PMLiVE

Microbiome specialist Rebiotix chalks up C. diff trial success

Drug therapy can prevent recurrent infections

A safe place to talk about Crohn’s

Published in eyeforpharma April 2017 by Mariel Metcalfe

Inizio

culture-cannot-be-global-cover

Culture cannot be global: doing business outside your comfort zone

Dorottya Okros of Blue Latitude Health talks through the common communication and negotiation pitfalls of working with Eastern Europe and the CIS for British presenters.

Blue Latitude Health

- PMLiVE

Neurocrine bags FDA approval for first tardive dyskinesia drug

Ingrezza edges ahead of Teva’s rival drug Austedo

Bristol Myers Squibb logo

Apexigen and BMS team up for lung cancer immunotherapy trial

Opdivo and APX005M used together may improve immune reaction

Patient Assistance Programme Evaluation for Cardiovascular Conditions

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

Inizio

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links